Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Antiemetics And Antinauseants Market In 2029?

In recent times, the market for antiemetics and antinauseants has seen stable growth. An expansion from $8.19 billion in 2024 to $8.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.6%, is expected. Factors contributing to the growth in the past have been traditional branding and market rivalry, historical treatment preferences, economic situations, past global health events, and advancements in medical research and development.

A consistent rise is anticipated in the size of the antiemetics and antinauseants market over the next several years, with a projected value of $9.64 billion in 2029 and a CAGR of 3.3%. This prospective growth within the forecasted period can be traced back to ongoing research and development endeavors, economic elements, market rivalry, and patterns within the industry, shifts in disease trends, and healthcare regulations and policies. Incoming trends expected during the prediction period comprise of a heightened emphasis on patient experiences, alterations in healthcare policies, the public’s preference for treatments that are non-invasive, an increase in the incidence of nausea related to chemotherapy and pregnancy, and the introduction of targeted therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Are the Core Growth Drivers Propelling the Antiemetics And Antinauseants Market Forward?

The rise in cancer prevalence is a key factor propelling the antiemetics and antinauseants market. As chemotherapy is commonly recommended to treat cancer, it often results in side effects such as chemotherapy-induced nausea and vomiting (CINV) which impact about 60%-70% patients. Antiemetics have been found to be effective in preventing these side effects. The American Cancer Society, a non-profit U.S based organization, estimated in April 2024 that roughly 609,000 deaths were linked to cancer and around 1.9 million new cases were diagnosed in the country in 2022. The prediction for an estimated 620,000 cancer deaths in 2024 indicates a slight rise in mortality rate. The growing cancer incidence signifies escalated demand for antiemetics and antinauseants, which in turn will boost the market revenue.

What Segment Types Define the Antiemetics And Antinauseants Market Structure?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theAntiemetics And Antinauseants Industry Evolution?

Leading firms in the antiemetic and antinauseant industry are striving for product innovation, particularly focusing on ready-to-use injectable solutions, to simplify treatment methods and improve patient adherence. These pre-prepared formulations aim to offer immediate effectiveness, cutting down the time and intricacy involved in conventional injectable medications. An example of this is Amneal Pharmaceuticals, a specialty pharmaceutical company located in the US, which introduced FOCINVEZ in July 2024. This was the initial ready-to-use injectable version of fosaprepitant, specifically created to thwart the onset of acute and delayed nausea and vomiting related to cancer chemotherapy that is highly emetogenic. The product can be obtained in a 150 mg/50 mL vial, excludes Polysorbate 80, and doesn’t necessitate reconstitution or dilution, thereby enabling straight administration. The use of FOCINVEZ has been approved for adults as well as pediatric patients who are six months and above, and it has been assigned a unique reimbursement J-Code (J1434).

View the full report here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Is the Definition of the Antiemetics And Antinauseants Market?

The antiemetics and antinauseants refer to drugs that are used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. Antiemetic and antinauseant drugs prevent, control, or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu, or chemotherapy. These drugs reduced the symptoms of nausea or vomiting by blocking signal messages to the part of the brain that controls nausea and vomiting.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model